Early detection of Alzheimer’s a step closer

Font Size:

Scientists have detected that a previously overlooked gene behaviour could potentially lead to a new way to diagnose Alzheimer’s earlier.

An international research team’s findings – discovered in mice and confirmed in human samples – suggest that the gene presenilin-1 (PSEN1) should be monitored as a ‘biomarker’: to see what environmental triggers, such as lifestyle and nutrition, can influence brain function and neurodegeneration or/and to see how well the body responds to a treatment for the disease.

The study, led by Professor Andrea Fuso at the Sapienza University of Rome, is the first to observe that the methylation (when the DNA activity of a gene can change, without changing the actual DNA sequence) of the gene PSEN1 is a common feature of Alzheimer’s.

The results of the study appear to show that PSEN1, which was already known to behave differently for people with Alzheimer’s, may have been dismissed in previous studies due to methods used to investigate DNA methylation.

The limitations of comparing results from mouse models and humans include mouse stages of development and neurodegeneration not corresponding precisely to those of human ageing.

In this study, the team noted that the blood and brain samples were obtained from different subjects. They suggested that future studies should analyse DNA from the same individuals, and in a larger cohort, in order to validate this potential biomarker.

However, Prof. Fuso believes that the new results do offer “an exciting new area of investigation”.

“We’ve detected an early sign of the disease in a DNA modification, or epigenetic marker, that was previously overlooked, and that could even provide a starting point for developing new therapies, as well as earlier diagnosis,” he added.

Worldwide, nearly 50 million people have Alzheimer’s or related dementia. Yet, only one in four people with Alzheimer’s disease have been diagnosed.

The earlier Alzheimer’s can be detected, the better the chance of using treatment to delay the onset of severe dementia.

Epigenetic alternations to genes, induced by environmental triggers such as lifestyle and nutrition, can influence brain function and neurodegeneration.

Evidence from animal models has found that changes to regulation of the PSEN1 gene is associated with Alzheimer’s-like pathology, but only a handful of studies have investigated DNA modification of the gene in humans.

For the current study, the authors analysed patterns of DNA modification that affect the expression of the PSEN1 gene during brain development and during the progression of Alzheimer’s in mice.

They checked the results in humans by analysing post-mortem human brain tissue from Alzheimer’s patients and from prenatal and postnatal babies and adolescents.

To see whether changes to DNA methylation could be detected in human blood, they analysed blood samples from 20 patients with late-onset Alzheimer’s disease, comparing the results to 20 healthy controls.

The analysis of blood samples was able to detect lower PSEN1-related DNA methylation in Alzheimer’s patients compared to controls. The difference was significant, although not as large as in brain samples. 

As lower methylation was detectable in the blood, and is associated with higher expression of PSEN1, it could offer a new way to diagnose Alzheimer’s early, and less invasively, than sampling brain tissue.

Are you worried you might develop Alzheimer’s or dementia?

If you enjoy our content, don’t keep it to yourself. Share our free eNews with your friends and encourage them to sign up.

Join YourLifeChoices today
and get this free eBook!

By joining YourLifeChoices you consent that you have read and agree to our Terms & Conditions and Privacy Policy


Busting sun and skin health myths

A study has revealed that Aussies could not distinguish fact from fiction when it comes to

Medicine safety for older Aussies ‘a game of Russian roulette’

The Pharmaceutical Society of Australia believes our most vulnerable are being put at risk.

Research questions effectiveness of mammograms

Researchers have found that women over 75 do not benefit from regular mammograms.

Written by Ben


Total Comments: 7
  1. 0

    so how do we get doctors to do this test?

    • 0

      You won’t yet because there is no real evidence of anything. Until there is real clinical evidence for doing the test and then what to do with the resultsyou will not get the teest even if you ask for it. Assuming it is even available outside the lab.

  2. 0

    so how do we get doctors to do this test?

  3. 0

    Given methylation seems to be involved here perhaps mutations on the mthfr genes may be taken more seriously now. We already know they are associated with some mental health illnesses!

  4. 0

    “The earlier Alzheimer’s can be detected, the better the chance of using treatment to delay the onset of severe dementia.”
    So what treatment might that be?

  5. 0

    I was going to come to but can’t remember what I wanted say !



continue reading

Technology News

Would you let AI choose your partner?

David Tuffley, Griffith University It could be argued that artificial intelligence (AI) is already the indispensable tool of the 21st...

Food and Recipes

How to spice up hummus

Few things are as universally loved as hummus. A blend of chickpeas, lemon, tahini, garlic, olive oil and cumin, whizzed...


Intensive care during COVID like a 'delirium factory', study finds

An international study of COVID-19 treatments has found patients admitted to intensive care early in the pandemic were treated by...


The surprising health and fitness benefits of golf

Recently, many have had to rely on walking or virtual fitness classes to keep going with their favourite sports and...


Five smart moves for empty nesters

So, the kids have moved out, your home is finally yours again and you have ascended to the rank of...


Why you turn down the radio when you're trying to park your car?

When you're looking for a destination, you might need to cut down the volume. Shutterstock Simon Lilburn, University of Melbourne...


Why we can expect smarter healthcare in 2021 and other tech trends

With last year dominated by the COVID-19 pandemic and much the same expected for 2021, it is unsurprising that healthcare...

Mental Health

Drug trial offers rare hope on Alzheimer's disease

There is finally a glimmer of hope in the fight against Alzheimer's, the most common form of dementia, which affects...